NCT03516695 - RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

December 12, 2018

Study Completion Date

December 12, 2018

Conditions

Liver Cancer

Interventions

DEVICE

TheraSphere®

Intra-arterial Yttrium-90 glass microspheres

Trial Locations (8)

New York University School of Medicine, New York

University of Miami, Coral Gables

Indiana University, Indianapolis

Allina Health System Virginia Piper Cancer Institute, Minneapolis

Regents of the University of Minnesota, Minneapolis

Rush University Medical Center, Chicago

UCLA, Los Angeles

University of Alberta, Edmonton